Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 April;61(2) > Minerva Cardioangiologica 2013 April;61(2):243-54



A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618


Minerva Cardioangiologica 2013 April;61(2):243-54


From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence

Navarese E. P. 1, Castriota F. 1, Sangiorgi G. M. 2, Cremonesi A. 1

1 Interventional Cardio-Angiology Unit, GVM Care and Research, Cotignola, Ravenna, Italy;
2 Department of Cardiology, Policlinico Tor Vergata, Rome, Italy

The implementation of methods of the coronary angioplasty was one of the most important achievement in the field of treatment of coronary artery disease. Abluminal biodegradable polymer stents (BDS) and polymer free stent are the newest and the most promising research concerning coronary stent technology. In this article we discuss the perceived need for BDS-polymer free stents, the current clinical evidence, limits and future perspectives.

language: English


top of page